Correspondence 0001493152-22-036124 from TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: Dec. 21, 2022 · CIK: 0001872812 · Accession: 0001493152-22-036124

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-268755

Date

Dec. 21, 2022

Author

Chief

Form

CORRESP

Company

TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)

Letter

TC BIOPHARM (HOLDINGS) PLC

Maxim 1, 2 Parklands Way

Holytown, Motherwell ML1 4WR

Scotland, United Kingdom

December 21, 2022

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Alan Campbell

Re: TC BioPharm (Holdings) plc

Registration Statement on Form F-1

File No. 333-268755

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Friday, December 23, 2022, or as soon thereafter as possible.

Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Very
truly yours,
TC
BIOPHARM (HOLDINGS) PLC

Show Raw Text

CORRESP
1
filename1.htm

TC
BIOPHARM (HOLDINGS) PLC

Maxim
1, 2 Parklands Way

Holytown,
Motherwell ML1 4WR

Scotland,
United Kingdom

December
21, 2022

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Alan Campbell

    Re:
    TC
    BioPharm (Holdings) plc

    Registration
    Statement on Form F-1

    File
    No. 333-268755

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings)
plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:00 p.m., Eastern Time, on Friday, December 23, 2022, or as soon thereafter as possible.

Please
notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Very
    truly yours,

    TC
    BIOPHARM (HOLDINGS) PLC

    By:
    /s/
    Bryan Kobel

    Name:
    Bryan
Kobel

    Title:
    Chief
    Executive Officer

SecProbe.io